These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Clinical application of 31P MRS to malignant liver tumors--with an emphasis on evaluation of response to therapy]. Saeki M; Ashida H; Imamura K; Fukui A; Ishizuka K; Kuwabara M; Wakabayashi M; Ishikawa T; Iwabuchi S; Mizuguchi A Nihon Igaku Hoshasen Gakkai Zasshi; 1992 Jun; 52(6):744-54. PubMed ID: 1322523 [TBL] [Abstract][Full Text] [Related]
4. Magnetic resonance imaging of cavernous hemangioma of the liver: tissue-specific characterization. Stark DD; Felder RC; Wittenberg J; Saini S; Butch RJ; White ME; Edelman RR; Mueller PR; Simeone JF; Cohen AM AJR Am J Roentgenol; 1985 Aug; 145(2):213-22. PubMed ID: 2992250 [TBL] [Abstract][Full Text] [Related]
5. [Differential diagnosis by MRT of cavernous hemangiomas and malignant tumors of the liver--advantages of the multi-echo technic]. Koch M; Lüning M; Mühler A; Simon C Radiol Diagn (Berl); 1990; 31(2):127-34. PubMed ID: 2160668 [TBL] [Abstract][Full Text] [Related]
9. Lobar intensity differences of the liver on MR imaging. Itai Y; Ohtomo K; Furui S; Minami M; Yoshikawa K; Yashiro N J Comput Assist Tomogr; 1986; 10(2):236-41. PubMed ID: 3005380 [TBL] [Abstract][Full Text] [Related]
10. Fast spin echo imaging with suspended respiration: gadolinium enhanced MR imaging of liver tumors. Mano I; Yoshida H; Nakabayashi K; Yashiro N; Iio M J Comput Assist Tomogr; 1987; 11(1):73-80. PubMed ID: 3027141 [TBL] [Abstract][Full Text] [Related]
11. Hepatic cancers and their response to chemoembolization therapy. Quantitative image-guided 31P magnetic resonance spectroscopy. Meyerhoff DJ; Karczmar GS; Valone F; Venook A; Matson GB; Weiner MW Invest Radiol; 1992 Jun; 27(6):456-64. PubMed ID: 1318873 [TBL] [Abstract][Full Text] [Related]
12. Hepatic malignant tumour versus cavernous haemangioma: differentiation on multiple breath-hold turbo spin-echo MRI sequences with different T2-weighting and T2-relaxation time measurements on a single slice multi-echo sequence. Chan YL; Lee SF; Yu SC; Lai P; Ching AS Clin Radiol; 2002 Apr; 57(4):250-7. PubMed ID: 12014868 [TBL] [Abstract][Full Text] [Related]
13. Phosphomonoester is associated with proliferation in human breast cancer: a 31P MRS study. Kalra R; Wade KE; Hands L; Styles P; Camplejohn R; Greenall M; Adams GE; Harris AL; Radda GK Br J Cancer; 1993 May; 67(5):1145-53. PubMed ID: 8494715 [TBL] [Abstract][Full Text] [Related]
14. Magnetic resonance imaging (MRI) in 100 cases of mass lesions in the liver. Meng T; Su XZ Chin Med J (Engl); 1990 Aug; 103(8):673-9. PubMed ID: 2173656 [TBL] [Abstract][Full Text] [Related]
15. [Characterization of hepatic neoplasms: contribution of magnetic resonance]. Gualdi GF; Volpe A; Polettini E; Ceroni AM; Melone A; Casciani E Clin Ter; 1994 Jul; 145(7):53-63. PubMed ID: 7955951 [TBL] [Abstract][Full Text] [Related]
17. Characterization of prostate cancer, benign prostatic hyperplasia and normal prostates using transrectal 31phosphorus magnetic resonance spectroscopy: a preliminary report. Narayan P; Jajodia P; Kurhanewicz J; Thomas A; MacDonald J; Hubesch B; Hedgcock M; Anderson CM; James TL; Tanagho EA J Urol; 1991 Jul; 146(1):66-74. PubMed ID: 1711587 [TBL] [Abstract][Full Text] [Related]
18. Magnetic resonance imaging of hepatic neoplasms. DiMarcangelo MT J Am Osteopath Assoc; 1992 Oct; 92(10):1261-6. PubMed ID: 1334061 [TBL] [Abstract][Full Text] [Related]
19. Hepatic tumors: differentiation by transverse relaxation time (T2) of magnetic resonance imaging. Ohtomo K; Itai Y; Furui S; Yashiro N; Yoshikawa K; Iio M Radiology; 1985 May; 155(2):421-3. PubMed ID: 2984719 [TBL] [Abstract][Full Text] [Related]
20. Evaluation of diffusion weighted imaging of magnetic resonance imaging in small focal hepatic lesions: a quantitative study in 56 cases. Quan XY; Sun XJ; Yu ZJ; Tang M Hepatobiliary Pancreat Dis Int; 2005 Aug; 4(3):406-9. PubMed ID: 16109526 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]